Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Oragenics Inca company focused on developing new treatments for brainrelated health conditions has completed a key study for their new concussion drug ONP This drug is designed to be delivered through the nose which could help it reach the brain quic...
SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure announced today that the company has signed an agreement to acquire a stake in Fina Biosolutions FinaBio a promising RD biotechn...
AviadoBio Ltdand Astellas Pharma Inc today announced an exclusive option and license agreement for AVB an investigational AAVbased gene therapy in Phase development for patients with frontotemporal dementia with progranulin mutations FTDGRN
MediLink TherapeuticsCo Ltda clinicalstage biotech company today announced a global clinical trial collaboration and supply agreement with Amgen Inc Amgen will lead a global clinical study to evaluate the therapeutic potential of the combination of M...
SK Biopharmaceuticals Latin American partner Eurofarma has submitted its new drug application NDA to Brazils health authority ANVISA for a fasttrack or prioritized approval of the antiseizure medication cenobamate The two sides forged a partnership i...
Synexa Life Sciences a specialist biomarker and bioanalysis service provider announces the acquisition of Alderley Analytical Ltd based near Manchester UK This transaction reflects an important milestone in Synexas buy and build growth strategy under...
AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd CSPC to advance the development of an early stage novel small molecule Lipoprotein a Lpa disruptor that has the potential to offer additional benefits for...
Daiichi Sankyotoday announced that it has submitted a supplemental New Drug Application sNDA to Japans Ministry of Health Labour and Welfare MHLW for ENHERTU trastuzumab deruxtecan for the treatment of adult patients with HER low IHC or IHC ISH or u...
Halozyme Therapeutics Inc today announced that argenx has nominated four new targets under its global collaboration and license agreement that provides argenx exclusive access to Halozymes ENHANZE drug delivery technology a proprietary recombinant hu...
AstraZenecas supplemental New Drug Application sNDA for Calquence acalabrutinib has been accepted and granted Priority Review in the US for the treatment of adult patients with previously untreated mantle cell lymphoma MCL The Food and Drug Administr...
